Online Program Home
My Program

CC = Colorado Convention Center   H = Hyatt Regency Denver at Colorado Convention Center
* = applied session       ! = JSM meeting theme

Activity Details

644 * ! Thu, 8/1/2019, 10:30 AM - 12:20 PM CC-607
Statistical Methods for the Co-Development of Drug and Companion Diagnostic in Oncology — Topic Contributed Papers
Section on Medical Devices and Diagnostics, Biopharmaceutical Section, Society for Medical Decision Making
Organizer(s): Rong Liu, Celgene
Chair(s): Frank Shen, Celgene Co.
10:35 AM Evaluation of Biomarker Threshold Designs in Cancer Therapy
Kui Shen, Bayer U.S. LLC; Xiaowen Tian, University of Washington; Jonathan Siegel, Bayer HealthCare Pharmaceuticals Inc.
10:55 AM A Case Study in Bridging for Companion Diagnostic Development: Pembrolizumab and PD-L1 Selected 2nd Line NSCLC Patients
Jared Lunceford, Merck & Co., Inc.; Ellie Corigliano, Merck & Co., Inc.; Siddhartha Mathur, Merck & Co., Inc.; Ziwen Wei, Merck & Co., Inc.; Yue Shentu, Merck & Co., Inc.
11:15 AM Drug-Device Co-Development in the Era of Precision Medicine: Industry Perspectives on Statistical Challenges
Shunguang Wang, Novartis Institutes for BioMedical Research Inc.
11:35 AM Logical Inference on Treatment Efficacy When Subgroups Exist

Ying Ding, University of Pittsburgh
11:55 AM Innovative Designs for Drug-Device Co-Development in the Area of Precision Medicine
Rui Tang, Servier
12:15 PM Floor Discussion